In addition, identification of these genetic modifiers and their roles may help to provide explanations for the heterogeneity and age-related penetrance of MEN1, as well as identifying tumour-associated pathways that may be targeted by anti-proliferative compounds. This evidence concerns the gene MEN1 and neoplasm.